CMMI - Centre de Recherche en Microscopie et Imagerie Médicale
Disciplines :
Radiology, nuclear medicine & imaging Zoology Chemistry
Author, co-author :
Dentamaro, Mario ; Université de Mons > Faculté de Médecine et de Pharmacie > Chimie générale, organique et biomédicale
Lux, F.
Vander Elst, Luce ; Université de Mons > Faculté de Médecine et de Pharmacie > Chimie générale, organique et biomédicale
Dauguet, Nicolas
Montante, Sylvie ; Université de Mons > Faculté de Médecine et de Pharmacie > Chimie générale, organique et biomédicale
Moussaron, Albert
Burtea, Carmen ; Université de Mons > Faculté de Médecine et de Pharmacie > Service de Chimie générale, organique et biomédicale
Muller, Robert ; Université de Mons > Unités externes > Center for Microscopy and Molecular Imaging ; Université de Mons > Faculté de Médecine et de Pharmacie > FMP - Service du Doyen
Tillement, O.
Laurent, Sophie ; Université de Mons > Faculté de Médecine et de Pharmacie > Chimie générale, organique et biomédicale
Language :
English
Title :
Chemical and in vitro characterizations of a promising bimodal AGuIX probe able to target apoptotic cells for applications in MRI and optical imaging
Publication date :
09 June 2016
Journal title :
Contrast Media and Molecular Imaging
ISSN :
1555-4309
Publisher :
John Wiley & Sons, Hoboken, United States - New Jersey
Volume :
11
Pages :
381-395
Peer reviewed :
Peer Reviewed verified by ORBi
Research unit :
M108 - Chimie générale, organique et biomédicale
Research institute :
R550 - Institut des Sciences et Technologies de la Santé R100 - Institut des Biosciences
Mignot A, Truillet C, Lux F, Sancey L, Louis C, Denat F, Boschetti F, Bocher L, Gloter A, Stéphan O, Antoine R, Dugourd P, Luneau D, Novitchi G, Figueiredo LC, De Morais PC, Bonneviot L, Albela B, Ribot F, Van Lokeren L, Déchamps-Olivier I, Chuburu F, Lemercier G, Villiers C, Marche PN, Le Duc G, Roux S, Tillement O, Perriat P. A top-down synthesis route to ultrasmall multifunctional Gd-based silica nanoparticles for theranostic applications. Chemistry 2013; 19: 6122–6136.
Sancey L, Lux F, Kotb S, Roux S, Dufort S, Bianchi A, Crémillieux Y, Fries P, Coll J-L, Rodriguez-Lafrasse C, Janier M, Dutreix M, Barberi-Heyob M, Boschetti F, Denat F, Louis C, Porcel E, Lacombe S, Le Duc G, Deutsch E, Perfettini J-L, Detappe A, Verry C, Berbeco R, Butterworth KT, McMahon SJ, Prise KM, Perriat P, Tillement O. The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy. Br J Radiol 2014; 87(1041: 20140134).
Bechet D, Auger F, Couleaud P, Marty E, Ravasi L, Durieux N, Bonnet C, Plénat F, Frochot C, Mordon S, Tillement O, Vanderesse R, Lux F, Perriat P, Guillemin F, Barberi-Heyob M. Multifunctional ultrasmall nanoplatforms for vascular-targeted interstitial photodynamic therapy of brain tumors guided by real-time MRI. Nanomedicine Nanotechnol Biol Med 2015; 11(3): 657–670.
Lux F, Mignot A, Mowat P, Louis C, Dufort S, Bernhard C, Denat F, Boschetti F, Brunet C, Antoine R, Dugourd P, Laurent S, Vander Elst L, Muller RN, Sancey L, Josserand V, Coll J-L, Stupar V, Barbier E, Rémy C, Broisat A, Ghezzi C, Le Duc G, Roux S, Perriat P, Tillement O. Ultrasmall rigid particles as multimodal probes for medical applications. Angew Chem Int Ed Engl 2011; 50(51): 12299–12303.
Sancey L, Kotb S, Truillet C, Appaix F, Marais A, Thomas E, Van der Sanden B, Klein J, Laurent B, Cottier M, Antoine R, Dugourd P, Panczer G, Lux F, Perriat P, Motto-Ros V, Tillement O. Long-term in vivo clearance of gadolinium-based AGuIX nanoparticles and their biocompatibility after systemic injection. ACS Nano 2015; 9(3): 2477–2488. doi:10.1021/acsnano.5b00552.
Benachour H, Bastogne T, Toussaint M, Chemli Y, Sève A, Frochot C, Lux F, Tillement O, Vanderesse R, Barberi-Heyob M. Real-time monitoring of photocytotoxicity in nanoparticles-based photodynamic therapy: a model-based approach. PLoS One 2012; 7(11): e48617. doi:10.1371/journal.pone.0048617.
Kobayashi K, Usami N, Porcel E, Lacombe S, Le Sech C. Enhancement of radiation effect by heavy elements. Mutat Res 2010; 704(1–3): 123–131.
Rima W, Sancey L, Aloy MT, Armandy E, Alcantara GB, Epicier T, Malchère A, Joly-Pottuz L, Mowat P, Lux F, Tillement O, Burdin B, Rivoire A, Boulé C, Anselme-Bertrand I, Pourchez J, Cottier M, Roux S, Rodriguez-Lafrasse C, Perriat P. Internalization pathways into cancer cells of gadolinium-based radiosensitizing nanoparticles. Biomaterials 2013; 34(1): 181–195. doi:10.1016/j.biomaterials.2012.09.029.
Luchette M, Korideck H, Makrigiorgos M, Tillement O, Berbeco R. Radiation dose enhancement of gadolinium-based AGuIX nanoparticles on HeLa cells. Nanomedicine 2014; 10(8): 1751–1755.
Porcel E, Tillement O, Lux F, Mowat P, Usami N, Kobayashi K, Furusawa Y, Le Sech C, Li S, Lacombe S. Gadolinium-based nanoparticles to improve the hadrontherapy performances. Nanomedicine 2014; 10(8): 1601–1608.
Le Duc G, Miladi I, Alric C, Mowat P, Bräuer-Krisch E, Bouchet A, Khalil E, Billotey C, Janier M, Lux F, Epicier T, Perriat P, Roux S, Tillement O. Toward an image guided microbeam radiation therapy using gadolinium-based nanoparticles. ACS Nano 2011; 5(12): 9566–9574.
Carrillo-Carrión C, Nazarenus M, Paradinas SS, Carregal-Romero S, Almendral MJ, Fuentes M, Pelaz B, Del Pino P, Hussain I, Clift MJ, Rothen-Rutishauser B, Liang X-J, Parak WJ. Metal ions in the context of nanoparticles toward biological applications. Curr Opin Chem Eng 2014; 4: 88–96.
Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 2000; 65(1/2): 271–284.
Benachour H, Sève A, Bastogne T, Frochot C, Vanderesse R, Jasniewski J, Miladi I, Billotey C, Tillement O, Lux F, Barberi-Heyob M. Multifunctional peptide-conjugated hybrid silica nanoparticles for photodynamic therapy and MRI. Theranostics 2012; 2(9): 889–904.
Morlieras J, Dufort S, Sancey L, Truillet C, Mignot A, Rossetti F, Dentamaro M, Laurent S, Vander Elst L, Muller RN, Antoine R, Dugourd P, Roux S, Perriat P, Lux F, Coll J-L, Tillement O. Functionalization of small rigid platforms with cyclic RGD peptides for targeting tumors overexpressing αvβ3-integrins. Bioconjug Chem 2013; 24(9): 1584–1597.
Morlieras J, Chezal J-M, Miot-Noirault E, Roux A, Heinrich-Balard L, Cohen R, Tarrit S, Truillet C, Mignot A, Hachani R, Kryza D, Antoine R, Dugourd P, Perriat P, Janier M, Sancey L, Lux F, Tillement O. Development of gadolinium based nanoparticles having an affinity towards melanin. Nanoscale 2013; 5(4): 1603–1615.
Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007; 35(4): 495–516.
Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995; 146(1): 3–15.
Burtea C, Laurent S, Lancelot E, Ballet S, Murariu O, Rousseaux O, Port M, Vander Elst L, Corot C, Muller RN. Peptidic targeting of phosphatidylserine for the MRI detection of apoptosis in atherosclerotic plaques. Mol Pharm 2009; 6(6): 1903–1919.
Khan KH, Blanco-Codesido M, Molife LR. Cancer therapeutics: targeting the apoptotic pathway. Crit Rev Oncol Hematol 2014; 90(3): 200–19. doi:10.1016/j.critrevonc.2013.12.012.
Mohammad RM, Muqbil I, Lowe L, Yedjou C, Hsu H-Y, Lin L-T, Siegelin MD, Fimognari C, Kumar NB, Dou QP, Yang H, Samadi AK, Russo GL, Spagnuolo C, Ray SK, Chakrabarti M, Morre JD, Coley HM, Honoki K, Fujii H, Georgakilas AG, Amedei A, Niccolai E, Amin A, Ashraf SS, Helferich WG, Yang X, Boosani CS, Guha G, Bhakta D, Ciriolo MR, Aquilano K, Chen S, Mohammed SI, Keith WN, Bilsland A, Halicka D, Nowsheen S, Azmi AS. Broad targeting of resistance to apoptosis in cancer. Semin Cancer Biol 2015; 35: 1–26.
Fulda S. Inhibitor of Apoptosis (IAP) proteins as therapeutic targets for radiosensitization of human cancers. Cancer Treat Rev 2012; 38(6): 760–766.
Soon S, Kim Y, Jin E, Hwa S, Choi J, Park J, Hee J, Jin K, Park J, Ji H, Jung E, Jin J, Jin D, Suh N, Cho D, Shin J, Yeol S, Kim BM, Jeong S, Kyung E. Ibulocydine sensitizes human cancers to radiotherapy by induction of mitochondria-mediated apoptosis. Radiother Oncol 2014; 112(2): 295–301. doi:10.1016/j.radonc.2014.07.005.
Bordón E, Henríquez-Hernández LA, Lara PC, Ruíz A, Pinar B, Rodríguez-Gallego C, Lloret M. Prediction of clinical toxicity in locally advanced head and neck cancer patients by radio-induced apoptosis in peripheral blood lymphocytes (PBLs). Radiat Oncol 2010; 5: 4.
Laumonier C. Imagerie moléculaire: recherche de vecteurs spécifiques de l'apoptose par la méthode du phage display. PhD Thesis. University of Mons-Hainaut, 2005; p. 111.
Laumonier C, Segers J, Laurent S, Michel A, Coppée F, Belayew A, Vander Elst L, Muller RN. A new peptidic vector for molecular imaging of apoptosis, identified by phage display technology. J Biomol Screen 2006; 11(5): 537–545.
Van Koninckxloo A, Henoumont C, Laurent S, Muller RN, Vander EL. NMR chemical shift study of the interaction of selected peptides with liposomal and micellar models of apoptotic cells. J Biol Inorg Chem 2014; 19(8): 1367–1376.
Le Duc G, Roux S, Paruta-Tuarez A, Dufort S, Brauer E, Marais A, Truillet C, Sancey L, Perriat P, Lux F, Tillement O. Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment. Cancer Nanotechnol 2014; 5: 4.
Moussaron A, Vibhute S, Bianchi A, Gündüz S, Kotb S, Sancey L, Motto-Ros V, Rizzitelli S, Crémillieux Y, Lux F, Logothetis NK, Tillement O, Angelovski G. Ultrasmall nanoplatforms as calcium-responsive contrast agents for magnetic resonance imaging. Small 2015; 11(37): 4900–4909. doi:10.1002/smll.201500312.
Wiener EC, Brechbiel MW, Brothers H, Magin RL, Gansow OA, Tomalia DA, Lauterbur PC. Dendrimer-based metal chelates: a new class of magnetic resonance imaging contrast agents. Magn Reson Med 1994; 31(1): 1–8.
Kruk D, Kowalewski J. General treatment of paramagnetic relaxation enhancement associated with translational diffusion. J Chem Phys 2009; 130(17): 1–13.
Helm L. Relaxivity in paramagnetic systems: theory and mechanisms. Prog Nucl Magn Reson Spectrosc 2006; 49(1): 45–64.
Tei L, Gugliotta G, Baranyai Z, Botta M. A new bifunctional GdIII complex of enhanced efficacy for MR-molecular imaging applications. Dalton Trans R Soc Chem 2009; 44: 9712–9714.
Mieville P, Jaccard H, Reviriego F, Tripier R, Helm L. Synthesis, complexation and NMR relaxation properties of Gd3+ complexes of Mes(DO3A)3. Dalton Trans R Soc Chem 2011; 40(16): 4260–4267.
Filippi M, Remotti D, Botta M, Terreno E, Tei L. GdDOTAGA(C18)2: an efficient amphiphilic Gd(III) chelate for the preparation of self-assembled high relaxivity MRI nanoprobes. Chem Commun R Soc Chem 2015; 51(98): 17455–17458.
Kielar F, Tei L, Terreno E, Botta M. Large relaxivity enhancement of paramagnetic lipid nanoparticles by restricting the local motions of the GdIII chelates. J Am Chem Soc 2010; 132(23): 7836–7837.
Vander Elst L, Sessoye A, Laurent S, Muller RN. Can the theoretical fitting of the proton-nuclear-magnetic-relaxation-dispersion (proton NMRD) curves of paramagnetic complexes be improved by independent measurement of their self-diffusion coefficients? Helv Chim Acta 2005; 88: 574–587.
Laurent S, Henoumont C, Vander Elst L, Muller RN. Synthesis and physicochemical characterisation of Gd-DTPA derivatives as contrast agents for MRI. Eur J Inorg Chem 2012; 12: 1889–1915.
Schmidt H, Scholze H, Kaiser A. Principles of hydrolysis and condensation reaction of alkoxysilanes. J Non-Cryst Solids 1984; 63: 1–11.
Truillet C, Lux F, Tillement O, Dugourd P, Antoine R. Coupling of HPLC with electrospray ionization mass spectrometry for studying the aging of ultrasmall multifunctional gadolinium-based silica nanoparticles. Anal Chem 2013; 85(21): 10440–10447.
Frangioni J. In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 2003; 7(5): 626–634.
Parmelee DJ, Walovitch RC, Ouellet HS, Lauffer RB. Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging. Invest Radiol 1997; 32(12): 741–747.
Henrotte V, Laurent S, Gabelica V, Vander Elst L, Depauw E, Muller RN. Investigation of non-covalent interactions between paramagnetic complexes and human serum albumin by electrospray mass spectrometry. Rapid Commun Mass Spectrom 2004; 18(17): 1919–1924.
Laurent S, Vander Elst L, Muller RN. Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. Contrast Media Mol Imaging 2006; 1(3): 128–137.
